SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,821 | -8.9% | 345 | -14.0% | 0.01% | -11.1% |
Q2 2023 | $45,922 | -16.9% | 401 | 0.0% | 0.01% | -18.2% |
Q1 2023 | $55,270 | +25.6% | 401 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $44,000 | +46.7% | 401 | 0.0% | 0.01% | +37.5% |
Q2 2022 | $30,000 | -11.8% | 401 | -7.6% | 0.01% | 0.0% |
Q1 2022 | $34,000 | -20.9% | 434 | -8.4% | 0.01% | -11.1% |
Q4 2021 | $43,000 | -2.3% | 474 | 0.0% | 0.01% | -18.2% |
Q3 2021 | $44,000 | +25.7% | 474 | +4.6% | 0.01% | +22.2% |
Q2 2021 | $35,000 | – | 453 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |